Диссертация (Клинико-генетический полиморфизм синдрома некомпактного миокарда левого желудочка у российских больных), страница 22

Genotype‐Positive Status Is Associated With Poor Prognoses inPatients With Left Ventricular Noncompaction Cardiomyopathy / S. Li, C. Zhang, N.Liu, H. Bai, C. Hou et al. // Journal of the American Heart Association – 2018 – Vol. 7,№20.79.Richard, P. Targeted panel sequencing in adult patients with left ventricularnon‐compaction reveals a large genetic heterogeneity / P. Richard,F. AderMaguelonne Roux, E. Donal, J.‐C. Eicher et al.

// Clinical Genetics – 2019 – Vol. 95,№3 – P. 356–367.80.Hershberger, R. E. Coding Sequence Mutations Identified in MYH7,TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 Patients with Familial orIdiopathic Dilated Cardiomyopathy / R. E. Hershberger, S. B. Parks, J. D.

Kushner, D.Li, S. Ludwigsen et al. // Clinical and Translational Science – 2008 – Vol. 1, №1 – P.21–26.81.Jordan, D. M. Development and Validation of a Computational Method forAssessment of Missense Variants in Hypertrophic Cardiomyopathy / D. M. Jordan, A.145Kiezun, S. M. Baxter, V. Agarwala, R. C. Green et al. // The American Journal ofHuman Genetics – 2011 – Vol. 88, №2 – P.183–192.82.Helms, A. S.

Sarcomere Mutation-Specific Expression Patterns in HumanHypertrophic Cardiomyopathy / A. S. Helms, F. Davis, D. Coleman, S. Bartolone, A. A.Glazier et al. // Circulation: Cardiovascular Genetics – 2014 – Vol. 7, № 4 – P. 434–443.83.Homburger, J. R. Multidimensional structure-function relationships inhuman β-cardiac myosin from population-scale genetic variation / J. R. Homburger, E.M. Greenb, C. Caleshuc, M. S. Sunithad, R. E. Taylor et al.

// Proceedings of theNational Academy of Sciences – 2016 – Vol. 113, № 24 – P. 6701–6706.84.Kelly, M. A. Adaptation and validation of the ACMG/AMP variantclassificationframeworkforMYH7-associatedinheritedcardiomyopathies:recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel / M. A. Kelly,C. Caleshu, A. Morales, J. Buchan, Z. Wolf et al., for the ClinGen CardiovascularClinical Domain Working Group // Genetics in Medicine – 2018 – Vol.

20, №3 – P.351–359.85.Semsarian, C. New Perspectives on the Prevalence of HypertrophicCardiomyopathy / C. Semsarian, J. Ingles, M. S. Maron, B. J. Maron // Journal of theAmerican College of Cardiology – 2015 – Vol. 65, № 12 – P.

1249–1254.86.Hershberger, R. E. Dilated cardiomyopathy: the complexity of a diversegenetic architecture / R. E. Hershberger, D. J. Hedges, A. Morales // Nature ReviewsCardiology – 2013 – Vol. 10, №9 – P. 531–547.87.;Richards, S. Standards and guidelines for the interpretation of sequencevariants: a joint consensus recommendation of the American College of MedicalGenetics and Genomics and the Association for Molecular Pathology / S. Richards, N.Aziz, S. Bale, D.

Bick, S. Das et al., on behalf of the ACMG Laboratory QualityAssurance Committee // Genetics in Medicine – 2015 – Vol.17, №5 – P. 405–423.14688.Pugh, T. J. The landscape of genetic variation in dilated cardiomyopathy assurveyed by clinical DNA sequencing / T. J.

Pugh, M. A. Kelly, S. Gowrisankar, E.Hynes, M. A. Seidman et al. // Genetics in Medicine – 2015 – Vol. 16, №8 – P. 601–608.89.Ehlermann, P. Adverse events in families with hypertrophic or dilatedcardiomyopathy and mutations in the MYBPC3 gene / P. Ehlermann, D. Weichenhan, J.Zehelein, H.

Steen, R. Pribe et al. // BMC Medical Genetics – 2008 – Vol.9 – P. 95.90.Erdmann, J. Spectrum of clinical phenotypes and gene variants in cardiacmyosin-binding protein C mutation carriers with hypertrophic cardiomyopathy / J.Erdmann, J. Raible, J. Maki-Abadi, J. Hammann, B. Wollnik et al. // Journal of theAmerican College of Cardiology – 2001 – Vol. 38, №2 – P. 322–330.91.van Velzen, H. G. Clinical Characteristics and Long-Term Outcome ofHypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding ProteinC) Founder Mutation / H.

G. van Velzen, A. F.L. Schinkel, R. A. Oldenburg, M. A. vanSlegtenhorst, I. M.E. Frohn-Mulder et al. // Circulation: Cardiovascular Genetic – 2017– Vol.10, №4.92.Barefield, D. Haploinsufficiency of Cardiac Myosin Binding Protein-C inthe Development of Hypertrophic Cardiomyopathy / D. Barefield // Dissertations– 2014– №1249.93.Hershberger, R. E. Progress with genetic cardiomyopathies: screening,counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventriculardysplasia/cardiomyopathy / R. E.

Hershberger, J. Cowan, A. Morales, J. D. Siegfried //Circulation: Heart Failure – 2009 – Vol.2, №3 – P. 253–26194.Monserrat, L. Mutation in the alpha-cardiac actin gene associated withapical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects/ L. Monserrat, M. Hermida-Prieto, X.

Fernandez Isabel Rodríguez, C. Dumont et al. //European Heart Journal – 2007 – Vol. 28, №16 – P.1953–1961.14795.Yoshida, Y. A novel ACTC1 mutation in a young boy with left ventricularnoncompaction and arrhythmias / Y. Yoshida, K. Hirono, K. Nakamura, T. Suzuki, Y.Hata, N. Nishida // HeartRhythm Case Reports – 2016 – Vol.2, №1 – P.92–97.96.Rodríguez-Serrano,M.FamilialLeftVentricularNoncompactionAssociated With a Novel Mutation in the Alpha-cardiac Actin Gene / M. RodríguezSerrano, D. Domingo, B. Igual, A.

Cano, P. Medina, E. Zorio // Revista Española deCardiología (English Edition) – 2014– Vol.67, №10 – P. 857–859.97.Ichida, F. Novel gene mutations in patients with left ventricularnoncompaction or Barth syndrome / F. Ichida, S. Tsubata, K.R. Bowles, N. Haneda, K.Uese et al. // Circulation – 2001 – Vol. 103, №9 – P. 1256–1263.98.Cao, Q. Phenotype and Functional Analyses in a Transgenic Mouse Modelof Left Ventricular Noncompaction Caused by a DTNA Mutation / Q.

Cao, Y. Shen, X.Liu, X. Yu, P. Yuan et al. // International Heart Journal – 2017 – Vol. 58, №6 – P.939–947.99.Brayson, D. Current insights into LMNA cardiomyopathies: Existingmodels and missing LINCs / D. Brayson, C. M. Shanahan // Nucleus – 2017 – Vol. 8, №1 – P. 17–33.100. Благова,О.В.Трансплантациясердцакакметодлеченияпрогрессирующей кардиомиопатии у больных с первичными миодистрофиями /О.В. Благова, А.В.

Недоступ, В.П. Седов, Е.А. Коган, А.Г. Шестак, М.Е. Поляк,Е.В. Заклязьминская // Клиническая и экспериментальная хирургия – 2017 – №3(17) – С. 34-48.101.Goldfarb, L. G. Missense mutations in desmin associated with familialcardiac and skeletal myopathy / L. G. Goldfarb, K.-Y. Park, L. Cervenáková, S.Gorokhova, H.-S. Lee et al.

// Nature Genetics – 1998 – Vol. 19, №4 – P. 402–403.102. van Acker, H. Dilated cardiomyopathy caused by a novel TNNT2 mutationadded value of genetic testing in the correct identification of affected subjects / H. Van148Acker, J. De Sutter, K. Vandekerckhove, T. J.

L. de Ravel, H. Verhaaren, J. De Backer// International Journal of Cardiology – 2010 – Vol. 144, №2 – P. 307–309.103. Sommese, R. F. Effects of troponin T cardiomyopathy mutations on thecalcium sensitivity of the regulated thin filament and the actomyosin cross-bridgekinetics of human β-cardiac myosin / R. F.

Sommese, S. Nag, S. Sutton, S. M. Miller, J.A. Spudich, K. M. Ruppel // PLoS ONE – 2013 – Vol. 8, №12 – P.e83403.104. Kassem, H. S. A comparative study of mutation screening of sarcomericgenes (MYBPC3 , MYH7 , TNNT2) using single gene approach versus targeted genepanel next generation sequencing in a cohort of HCM patients in Egypt / H. Sh.Kassem, R. Walsh, P. J.

Barton, B. S. Abdelghany, R. S. Azer et. al. // Egyptian Journalof Medical Human Genetics – 2017 – Vol.18, №4 – P.381–387.105. Maron, B. J. Double or compound sarcomere mutations in hypertrophiccardiomyopathy: A potential link to sudden death in the absence of conventional riskfactors / B. J.

Maron, M. S. Maron, C. Semsarian // Heart Rhythm – 2012 – Vol. 9, №1– P.57–63.106. Fatkin, D. Neonatal cardiomyopathy in mice homozygous for theArg403Gln mutation in the α cardiac myosin heavy chain gene / D. Fatkin, M. E.Christe, O. Aristizabal, B. K. McConnell, S. Srinivasan et al. // Journal of ClinicalInvestigation – 1999 – Vol.103, №1 – P.147–153..